The first bellwether trial in a low T medication class action lawsuit has already reached a verdict. On July 17, 2017, a Chicago jury ordered AbbVie to pay plaintiff Jesse Mitchell $150 million in punitive damages. Mitchell, who took AndroGel for four years before suffering a heart attack in 2012, sued AbbVie in 2014.
Court Rules That Ads “Falsely Marketed” AndroGel to Men
The first test trial’s outcome offers hope for thousands of plaintiffs with pending low t medication lawsuits. These suits say manufacturers knowingly participated in “aggressive disease awareness” campaigns. In addition, these marketing claims target men who might suffer from low testosterone. For this reason, a significant number of men asked doctors for prescription low t medication. For at least some affected men, these low t medication prescriptions may have caused more harm than good.
Apparently, jurors in the first federal case tried this year agreed, saying that “the company falsely marketed the drug.” However, they did not award Mitchell any compensatory damages due to his injuries or associated losses. University of Richmond law professor Carl Tobias called the first bellwether trial’s verdict “extremely unusual.” In a recent Reuters interview, Tobias stated: “The fact that a jury awarded punitive damages may encourage plaintiffs and their lawyers to bring on more cases and pursue them even more aggressively.”
Over 6,000 Low T Medication Lawsuits Are Still Pending
Men taking low t medication are filing lawsuits due to the following cardiovascular side effects:
- Heart attack
- Pulmonary embolism
- Deep vein thrombosis (DVT)
- Other cardiac event
And these men have reason for concern. In January 2014, the U.S. Food and Drug Administration issued a low t drug safety warning. Unfortunately, since the FDA initially approved AndroGel in 2003, this warning came 11 years too late for some men.
In addition to AndroGel manufacturer AbbVie Inc., low t medication lawsuits are now underway against:
- Eli Lilly and Co.
- Abbott Laboratories
- Lilly USA, LLC
- Endo Pharmaceuticals, Inc.
You May Qualify for Low T Medication Compensation
If you or someone you love had a cardiac event while taking low t medication, you may qualify for compensation. To see if you may be eligible for a cash settlement, complete your free compensation evaluation form now. Once you’ve submitted your information, an experienced advocate will call to discuss your compensation options.